Stockle - the stock oracle

DENBURY INC

US:DNRRWUS:DNRWWUS:DNRCQ
No current share price held for this company.

Past year: ▼ 42%(31.20 – 58.75 USD)

Market cap
—
Shares on issue
—
Story beats
34 since 2012
Last event
22 Nov 2023

Announcements, explained

Each one in plain English, with the numbers worked through for a shareholder.

18 Sept 2020listing compliance notice▲ GoodMajor

the exchange certified DENBURY INC's securities for listing, clearing them to begin trading.

Discuss in chat

18 Sept 2020securities registration● Neutral

DENBURY INC amended its automatic shelf registration statement.

Discuss in chat

17 Aug 2020listing compliance notice● NeutralMajor

DENBURY INC's exchange filed to remove a class of its securities from listing.

Discuss in chat

11 Aug 2020quarterly activities report▼ Bad

DENBURY INC reported quarterly revenue of $117.9 million and a net loss of $697.5 million for the period ended 2020-06-30.

Discuss in chat

11 Aug 2020quarterly activities report▼ Bad

DENBURY INC reported quarterly revenue of $117.9 million and a net loss of $697.5 million for the period ended 2020-06-30.

Discuss in chat

11 Aug 2020late filing notice▼ Bad

DENBURY INC notified the SEC that its quarterly report would be filed late.

Discuss in chat

7 Aug 2020substantial holder notice● Neutral

BlackRock, Inc reported no remaining DENBURY INC shareholding in its periodic institutional filing.

Discuss in chat

10 July 2020substantial holder notice● Neutral

BlackRock, Inc reported a DENBURY INC shareholding of 49,093,885 shares (9.70% of votes) in a periodic institutional filing.

Discuss in chat

10 July 2020substantial holder notice● Neutral

The Vanguard Group reported a DENBURY INC shareholding of 37,481,790 shares (7.40% of votes) in a periodic institutional filing.

Discuss in chat

30 June 2020debt financing▼ BadMajor

On 26 June 2020 Denbury signed an Eighth Amendment to its bank credit agreement. It reaffirmed the $615m borrowing base but temporarily cut maximum availability to $275m plus outstanding letters of credit (up to $100m) until the fall 2020 redetermination, and added temporary dollar limits on certain covenant baskets. Denbury also chose not to pay the roughly $8m interest due 30 June 2020 on its 6⅜% convertible notes due 2024 'to evaluate certain strategic alternatives', none implemented yet. A 30-day grace period applies before it becomes an event of default. It drew $200m on the credit facility on 29 June as a precaution, leaving $265m borrowed and about $95m of letters of credit. Skipping the interest payment and drawing the facility is a negative signal for shareholders and raises the risk to their position; the filing does not say what the alternatives are.

Discuss in chat

11 June 2020director interest notice● Neutral

DENBURY INC VP & Chief Accounting Officer Alan Rhoades disposed of 335,532 shares via option/appreciation-right settlement.

Discuss in chat

11 June 2020director interest notice● Neutral

DENBURY INC EVP, CAO, GC & Sec'y James S. Matthews disposed of 296,362 shares via option/appreciation-right settlement.

Discuss in chat

11 June 2020director interest notice● Neutral

DENBURY INC President and CEO Christian S Kendall disposed of 1,205,049 shares via option/appreciation-right settlement.

Discuss in chat

18 May 2020quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $242.2 million and net income of $74.0 million for the period ended 2020-03-31.

Discuss in chat

18 May 2020quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $242.2 million and net income of $74.0 million for the period ended 2020-03-31.

Discuss in chat

6 Mar 2020listing compliance notice▼ BadMajor

On 5 March 2020 the NYSE told Denbury its average share price over 30 trading days was below $1.00, the minimum for listing. Denbury has six months to cure, and says it is considering options including a reverse stock split, which needs board and stockholder approval. The shares keep trading as DNR with a '.BC' (below compliance) marker, and the company says the notice does not trigger any violation of its debt obligations. Failure to cure could lead to delisting.

Discuss in chat

11 Feb 2020substantial holder notice● Neutral

The Vanguard Group reported a DENBURY INC shareholding of 69,375,119 shares (14.35% of votes) in a periodic institutional filing.

Discuss in chat

4 Feb 2020substantial holder notice● Neutral

BlackRock, Inc reported a DENBURY INC shareholding of 74,867,065 shares (14.70% of votes) in a periodic institutional filing.

Discuss in chat

25 Nov 2019capital raising announcement● Neutral

On 22 November 2019 Denbury agreed to issue 15,150,000 common shares and pay $2.95m cash for $8.75m of 5½% 2022 and $25.361m of 4⅝% 2023 subordinated notes. This is another round of the same share-for-debt exchanges and is the largest share issuance of the series so far, so it dilutes existing shareholders further.

Discuss in chat

15 Nov 2019capital raising announcement● Neutral

Between 11 and 14 November 2019 Denbury agreed to issue 9,447,217 common shares and pay $2,270,850 cash for $3.071m of 5½% 2022 and $21.077m of 4⅝% 2023 subordinated notes. This continues the October pattern of swapping sub notes for shares and some cash, and adds further dilution for existing shareholders.

Discuss in chat

8 Nov 2019quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $315.5 million and net income of $72.9 million for the period ended 2019-09-30.

Discuss in chat

7 Nov 2019quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $315.5 million and net income of $72.9 million for the period ended 2019-09-30.

Discuss in chat

17 Oct 2019capital raising announcement● NeutralMajor

Between 7 and 16 October 2019 Denbury agreed to issue 13,690,000 common shares and pay $5.8m cash for $13.2m of 5½% 2022 and $29.3m of 4⅝% 2023 subordinated notes. It also bought back $11.3m of 2022 notes on the open market for about $5.4m. In total it retired $53.8m (about 15%) of its $357.8m of sub notes outstanding at 30 June 2019, for about $11.2m cash plus the new shares. This continues the debt-reduction exchanges, now paid partly in stock, which dilutes existing shareholders. The company says it may do more but is not obliged to.

Discuss in chat

9 Aug 2019quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $343.4 million and net income of $146.7 million for the period ended 2019-06-30.

Discuss in chat

7 Aug 2019quarterly activities report● Neutral

DENBURY INC reported quarterly revenue of $343.4 million and net income of $146.7 million for the period ended 2019-06-30.

Discuss in chat

2 July 2019debt financing● Neutral

On 1 July 2019 Denbury did the final settlement of the second lien exchange, accepting about $4.0m of old 7½% second lien notes for about $3.8m of new 7¾% second lien notes. Including the June settlement, the totals are $152.2m of 2021 sub notes, $219.9m of 2022 sub notes, $96.3m of 2023 sub notes and $429.4m of old second liens exchanged for about $120.0m cash, $531.8m new second liens and $245.5m new 6⅜% convertibles. This closes out the June 2019 exchange; the remainder of the filing is collateral paperwork.

Discuss in chat

24 June 2019capital raising announcement● NeutralMajor

On 19 June 2019 Denbury settled the early-participation part of the exchange announced 3 June. It accepted about $152.2m of 6⅜% 2021 sub notes, $219.9m of 5½% 2022 sub notes, $96.3m of 4⅝% 2023 sub notes and $425.4m of old 7½% second lien notes. In return it issued about $528.0m of new 7¾% second lien notes due 2024 and $245.5m of new 6⅜% convertible notes due 2024, and paid about $120.0m cash. The new convertibles convert at 370 shares per $1,000 and auto-convert if the share price stays at or above $2.43 (10 of 15 trading days), so shareholders face possible dilution (the earlier context put the maximum at ~92m shares). This completes the pending exchange's main settlement; the filing text was truncated after the convertible terms.

Discuss in chat

3 June 2019capital raising announcement● NeutralMajor

On 3 June 2019 Denbury announced private exchange agreements and public exchange offers to swap its 6⅜% subordinated notes due 2021, 5½% subordinated notes due 2022 and 7½% second lien notes due 2024 for new 7¾% second lien notes due 2024, new 6⅜% convertible notes due 2024, or cash. The private deals cover about $44.8m of 2021 notes, $93.1m of 2022 notes and $96.3m of 4⅝% 2023 notes for about $48.5m cash, $36.6m new second lien notes and $149.1m new convertible notes, plus $168.0m of old second liens for the same amount of new second liens. The new convertibles convert at 370 shares per $1,000 (about $2.70 per share), with up to about 92 million shares possible, so this could dilute shareholders if the notes convert. This continues the earlier pattern of note exchanges; closing depends on the exchange offers completing.

Discuss in chat

9 May 2019quarterly activities report▼ Bad

DENBURY INC reported quarterly revenue of $305.5 million and a net loss of $25.7 million for the period ended 2019-03-31.

Discuss in chat

7 May 2019quarterly activities report▼ Bad

DENBURY INC reported quarterly revenue of $305.5 million and a net loss of $25.7 million for the period ended 2019-03-31.

Discuss in chat